Uncertainties in Internal Dose Calculations for Radiopharmaceuticals

¹ Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, Tennessee

^* To whom correspondence should be addressed. E-mail: michael.g.stabin{at}vanderbilt.edu.

	Abstract

This paper presents a systematic analysis of the inherent uncertainty in internal dose calculations for radiopharmaceuticals. A generic equation for internal dose is presented, and the uncertainty in each of the individual terms is analyzed, with the relative uncertainty of all terms compared. The combined uncertainties in most radiopharmaceutical dose estimates will be typically at least a factor of 2 and may be considerably greater. In therapy applications, if patient-individualized absorbed doses are calculated, with attention being paid to accurate data gathering and analysis and measurement of individual organ volumes, many of the model-based uncertainties can be removed, and the total uncertainty in an individual dose estimate can be reduced to a value of perhaps ±10%–20%. Radiation dose estimates for different diagnostic radiopharmaceuticals should be appreciated and considered, but small differences in dose estimates between radiopharmaceuticals should not be given too much importance when one is choosing radiopharmaceuticals for general clinical use. Diagnostic accuracy, ease of use, image quality, patient comfort, and other similar factors should predominate in the evaluation, with radiation dose being another issue considered while balancing risks and benefits appropriately.

Key Words: radiobiology/dosimetry, radiopharmaceuticals, radiation safety, internal dose assessment, radiopharmaceuticals, uncertainty

This article has been cited by other articles:

				M. G. Stabin Radiopharmaceuticals for Nuclear Cardiology: Radiation Dosimetry, Uncertainties, and Risk J. Nucl. Med., September 1, 2008; 49(9): 1555 - 1563. [Abstract] [Full Text] [PDF]